Articles tagged with Cancer Treatments
Researchers develop flexible vaccine platform for single-dose protection against a range of infectious diseases. The technology offers rapid, large-scale production and is suitable for repeated use.
Developing cancer was associated with an increased risk of new type 2 diabetes, even after accounting for precancer risk factors. The risk was highest in the first two years after diagnosis.
New research funded by Cancer Research UK found that people using high nicotine e-liquid puffed less deeply and often than those using low nicotine liquid. The study also showed that high nicotine vapers had lower levels of toxic chemicals in their vapour compared to low nicotine users.
Breast cancer patients aged 70 and over in England have a higher risk of mortality due to reduced surgical intervention compared to other countries. Patients with stage three breast cancer in England are also more likely to not receive surgery, which has been linked to poorer survival rates.
The NCI-MATCH trial has released findings from three treatment arms, offering hope for targeted therapies in patients with specific gene abnormalities. The trial's results could aid in identifying effective treatments for various cancers, paving the way for future research.
The UKPID registry has provided valuable information on PID in the UK, especially regarding delays to diagnosis. The data show that longer diagnostic delays can lead to poorer long-term outcomes for patients.
The University of Surrey has created a mathematical model that more accurately details how hepatitis C (HCV) infection develops and behaves. This new model could lead to improved treatment for the infection affecting 215,000 people in the UK.
Breakthrough lab-on-a-chip technology allows scientists to isolate single cells, analyse them in real time and observe their complex signalling behaviour. This technology holds great promise for developing new treatments for diseases.
Researchers from EPFL have created an optofluidic device that allows them to observe cells in real-time without disrupting their environment. This technology enables the monitoring of chemical secretions and offers a powerful tool for studying individual cell behavior, which can inform new treatments for cancer and autoimmune diseases.
The DFG is supporting top-level research at German universities with 14 new CRCs, covering topics like life emergence and hearing acoustics. The programme aims to improve understanding of diseases through innovative research projects.
A lower-fat diet was linked to increased breast cancer overall survival among postmenopausal women, although the increase may be partly due to better survival from other causes. The study found modest increases in vegetable, fruit, and grain intake in the lower-fat group.
A population-based registry study confirms that secondary surgery can delay recurrence by two years and improve median overall survival by at least six years. The treatment model is centralized in Norway, which led to the favorable results, and may be adopted by other countries.
Two studies found that more frequent follow-up testing did not significantly impact mortality rates from any cause or colorectal cancer over five years. However, a related editorial suggests that current guidelines should be reevaluated in the context of these findings and potential harms associated with more frequent testing.
Dr. Michel Sadelain shares his role in advancing CAR T-cell therapy, a rapidly evolving field that targets cancer cells. He describes the FDA approval of the first CAR T-cell therapy and predicts next-generation technology advancements.
A new study reveals declines in prostate cancer screening and diagnoses in the US between 2008-2014, with significant decreases in definitive treatments. The findings suggest that men are choosing active surveillance for low-risk prostate cancer, avoiding treatment-related harms.
Researchers developed an algorithm to predict treatment effectiveness in individual patients using a molecular communication pathway. The study found that repurposing ruxolitinib, a drug approved for malignant blood disorders, can overcome resistance to measles virotherapy by increasing its effectiveness by a factor of 1,000.
A new special issue of the Journal of Dental Research brings together leaders in the field to discuss the state-of-the-science in head and neck cancer, presenting new early diagnostic tools and mechanism-based therapies.
Researchers developed a novel inertial cell focusing and sorting microfluidic device with a wavy channel structure, achieving size-based separation of target cells. The device offers high-throughput, low-energy consumption, and simplified setup, making it suitable for practical biomedical applications.
Researchers found that continued treatment of muscle wasting with a soluble growth factor receptor protein improved survival in a pre-clinical cancer model. The study suggests a possible causal link between preserving muscle mass and improved survival, but notes that other factors may also play a role.
A study by Duke University Medical Center researchers has identified early cell movement as a potential indicator of malignant tumors in colorectal cancer. The team analyzed 19 human colorectal tumors, finding that invasive samples exhibited signatures of abnormal cell movement more frequently than benign tumors.
Researchers have developed criteria for routine genetic screening of patients with medulloblastoma, a rare and malignant tumor predominantly affecting children. This analysis of 1022 patients identified six genes frequently affected by genetic alterations, increasing cancer risk in up to 20% of the patient population.
A new study found that patients with low risk of local recurrence can safely undergo surgery alone without receiving chemoradiotherapy. This strategy could reduce the number of patients who receive chemoradiotherapy by half, with minimal risk of undertreatment.
A new tool uses high-throughput DNA sequencing to accurately predict which early-stage Cutaneous T Cell Lymphoma (CTCL) patients are at risk of developing an aggressive form of the disease. The tool, which analyzes specific genes, has shown promise in improving treatment outcomes for these patients.
A new biomarker, CKAP4, has been identified in patients with stage I lung cancer, offering a potential non-invasive diagnostic marker that could improve patient outcomes. The sensitivity of serum CKAP4 was found to be higher than current sero-diagnostic markers.
A new study by Sanford Burnham Prebys Medical Discovery Institute (SBP) researchers describes how nuclear pore component Nup210 is critical for the survival of circulating CD4+ T cells. The findings identify a new node of T cell receptor signaling and could pave the way for the development of future immunotherapies.
A study found that parenting concerns about the impact of illness on minor children have a strong negative association with health-related quality of life among women with metastatic cancer. The researchers recommend interventions to reduce psychological concerns and assess parenting concerns in patient care.
A study published in the British Journal of Cancer found that men with testicular cancer who underwent vigorous exercise improved their energy levels and self-esteem. High-intensity interval training was particularly effective in reducing tiredness and improving overall vitality.
A recent study by Michigan Medicine has found that over one-third of cirrhosis cases are related to alcohol consumption, with women being disproportionately affected. The study reveals that patients with alcohol-related cirrhosis have higher healthcare costs and poorer health outcomes compared to those without the condition.
A systematic review and meta-analysis found that psychological interventions using cognitive behavioral approaches can reduce chronic pain intensity and improve self-efficacy in older adults. However, the study's limitations highlight the need for further research to develop more effective treatments.
A team of melanoma experts at Moffitt's Center of Excellence will investigate the causes and drivers of acral melanoma, a rare form of skin cancer affecting African-Americans. The three-year grant aims to develop better prevention and treatment strategies for this aggressive disease.
New research from UBC Okanagan shows that community-based initiatives and microgrants are effective in increasing physical activity among breast cancer survivors. The program, Project MOVE, supports community-led interventions and fosters social support and confidence
A new web-based support programme offers online cognitive behavioural therapy and peer support to survivors of prostate cancer, aiming to improve their mental health. The programme has shown promising results in reducing distress and improving quality of life among men recovering from the disease.
A recent study published in Cell Reports has revealed that mutant Isocitrate dehydrogenase 1 (IDH1) drives glioma development by cooperating with multiple mutations and events in brain tumor cells. This breakthrough discovery provides substantial evidence for the functional role of mutant IDH1 in tumorigenesis.
Researchers at UTHealth and Ohio State University combined virotherapy with boosting the natural immune system to fight cancer. The study found that increasing the number of externally added NK cells strengthens the ability to fight cancer.
Treating leg ulcers within two weeks improves healing rates by 12% compared to standard treatment, with a success rate of 85.6%. Early intervention helps patients recover quicker and reduces the risk of complications such as amputation.
Researchers at Sanford Burnham Prebys Medical Discovery Institute discovered that PKC zeta deficiency promotes liver metastasis through the inactivation of enzyme ADAR2, leading to increased secretion of miR-200s. Treatment with a compound inhibiting miR-200s reduced liver metastasis in mice with colorectal cancer.
Increasing tumor size relative to testis size is linked to reduced sperm production in men with testicular cancer. The rule of 50s suggests that men with a testis tumor occupying greater than 50% of their testis have less than a 50% chance of sperm production.
Researchers discover urethane, a compound formed during beer and wine fermentation, is more effective at combating seizures caused by organophosphate nerve agents than the current recommended treatment. The study suggests urethane or its derivative may prevent seizures from developing into epilepsy.
The Pancreatic Cancer Collective, funded by the Lustgarten Foundation and Stand Up To Cancer, will accelerate research for pancreatic cancer patients. The initiative aims to improve diagnosis and treatments, as well as support the next generation of pancreatic cancer investigators.
Researchers developed a powerful mouse model using CRISPR-Cas9 and RCAS/TVA system to mimic glioma genetic alterations. The model enables the study of gene fusions and mutations in cancer progression and treatment response.
A real-world study found that patients with chronic hepatitis C virus infection who achieve a sustained virological response (SVR) after direct-acting antiviral agent (DAA) treatment have lower all-cause mortality. Achieving SVR reduced mortality from both liver-related and unrelated causes at all stages of disease.
The study confirms that long-term OCA treatment leads to reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis (PBC) who have had an incomplete response to ursodeoxycholic acid (UDCA). The majority of patients improved or maintained their histological stage, while two patients deteriorated.
Researchers engineered a donor cornea with genes that inhibit vascularization, reducing the risk of tissue rejection in high-risk patients. The study shows promising results for gene therapy in preventing corneal graft rejection.
DAAs therapy in Scotland significantly reduced HCV-related decompensated cirrhosis presentations, with a 29-39% reduction. Early treatment initiation also showed lower lifetime costs and quality-adjusted life years.
Researchers discovered three evolutionarily distinct types of kidney cancer, each with its own evolutionary path. The study sheds light on the fundamental principles of cancer evolution and could lead to future clinical tests for more accurate prognoses and personalized treatment.
Recent studies in the Journal of Lipid Research reveal that dietary lipids can either treat or exacerbate diseases, depending on their type. The ketogenic diet has shown mixed results as a cancer therapy, while polyunsaturated fats like omega-3 and omega-6 have different effects on inflammation and brown fat formation.
Researchers developed personalized T cell adoptive immunotherapy for patients with HBV-related HCC, resulting in an objective positive response with volumetric reduction of lung lesions and no new lesions detected. The therapy showed promise with no therapy-related adverse events.
A new assay using droplet digital PCR has been developed to detect closed circular DNA (cccDNA) in serum, single cells, and preserved tissue samples. This allows for the early detection of hepatocellular carcinoma (HCC) and more effective treatment.
A new study reports that consuming high amounts of carbohydrates and sugar prior to treatment for head and neck cancer may increase patients' risks of cancer recurrence and mortality. However, moderate fat and starchy food consumption after treatment appears to have protective benefits, reducing disease recurrence and death rates.
The ALS Association granted Lauren Sciences LLC its third award for developing LAUR-301, a V-Smart Nanomedicine for ALS. LAUR-301 aims to deliver GDNF across the blood-brain barrier and induce neuro-restoration in all ALS patients.
A new study suggests that high-quality cervical cancer screening can be effectively done using automated technology, which could improve coverage in underserved regions. The researchers developed a novel risk score algorithm based on computer-scanned liquid-based slide features to separate HPV-positive women for treatment.
Researchers at Sanford Burnham Prebys Medical Discovery Institute reveal that the loss of p62 in fat cells fuels aggressive prostate cancer by inhibiting energy-consuming processes. This discovery opens new avenues for therapeutic targeting and highlights the importance of considering whole-body metabolism in cancer treatment.
Researchers found that oral sirolimus treatment significantly improved pulmonary function and reduced carcinoid tumor volume in three patients with DIPNECH syndrome. The study provides promising evidence for sirolimus as a viable treatment option for this rare condition.
The American Society for Gastrointestinal Endoscopy has released new guidelines for the use of endoscopic eradication therapy in patients with Barrett's esophagus, a precursor to esophageal adenocarcinoma. The guidelines support evidence-based recommendations and clinical guidelines addressing key issues related to Endoscopic Eradicati...
Researchers developed an index measuring similarity between cancer cells and pluripotent stem cells to predict tumor aggressiveness, treatment resistance, and clinical outcome. The index may help identify novel therapeutic targets against cancer by pinpointing the point at which tumor cells acquire stem cell-like characteristics.
A study published in Journal of the American Academy of Dermatology found an FDA-approved topical solution to be less cytotoxic and damaging to melanocytes than cryosurgery, suggesting a safer option for seborrheic keratosis removal
Patients with alcohol-related liver cancer tend to have poorer overall survival rates compared to those with non-alcohol related liver cancer. The study highlights the need for improved screening and treatment programs for patients at risk of developing cirrhosis or liver cancer, especially those who are still drinking.
A research team at Case Western Reserve University is developing an AI-powered tool to analyze computerized images of tissue samples for patterns that can predict the risk of recurrence in oropharyngeal cancers. This could lead to more personalized treatment approaches for patients with these aggressive tumors.
A new quality improvement initiative, NAPRC, aims to improve US rectal cancer care by adopting a multidisciplinary team approach. The program's proposed quality measures and process indicators were analyzed, revealing varying completion rates among hospitals.
Scientists identified a mechanism of resistance to ibrutinib, a current treatment for non-Hodgkin lymphoma, and discovered a promising therapeutic target in three enzymes. Blocking these enzymes with masitinib completely ablated the B-cell receptor pro-tumorigenic signals.